Abstract Details

Title Neurology Residents Believe That More Interventional Neurology Exposure Will Translate into Better Patient Care: A Nationwide Survey

Topic Neurologic ��ɫ��

Presentation(s) (-)

Poster/Presentation
Number 009

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Mohammad Moussavi, MD	Dr. Moussavi has nothing to disclose.
	No disclosure on file
Martin Gizzi, MD, PhD, FAAN	No disclosure on file
Thomas A. Berger, MD (Dept. of Neurology, Medical University of Vienna)	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
	No disclosure on file

��ɫ����